The Journal of Allergy and Clinical Immunology
Volume 121, Issue 5 , Pages 1140-1147.e2, May 2008

Surfactant protein D alters allergic lung responses in mice and human subjects

  • Eric B. Brandt, PhD

      Affiliations

    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • ,
  • Melissa K. Mingler, MS

      Affiliations

    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • ,
  • Michelle D. Stevenson, MD

      Affiliations

    • Division of Emergency Medicine, Akron Children's Hospital and Northeastern Ohio Universities College of Medicine, Akron, Ohio
  • ,
  • Ning Wang, PhD

      Affiliations

    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • ,
  • Gurjit K. Khurana Hershey, MD, PhD

      Affiliations

    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • ,
  • Jeffrey A. Whitsett, MD

      Affiliations

    • Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • ,
  • Marc E. Rothenberg, MD, PhD

      Affiliations

    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • Corresponding Author InformationReprint requests: Marc E. Rothenberg, MD, PhD, Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229.

Received 6 June 2007; received in revised form 12 February 2008; accepted 12 February 2008. published online 20 March 2008.

Background

Surfactant protein (SP) D has been proposed to be protective in allergic airway responses.

Objective

We aimed to determine the effect of SP-D deficiency on murine and human airway allergy.

Methods

Immunologic responses of SP-D gene–deficient mice (Sftpd−/−) at baseline and after 4 intranasal Aspergillus fumigatus exposures were assessed. In addition, the significance of a single nucleotide polymorphism (Met11Thr) in the human SP-D gene (known to decrease SP-D function) was investigated.

Results

Macrophage and neutrophil bronchoalveolar lavage fluid levels and large airway mucus production were increased in naive Sftpd−/− mice in association with increased lung CCL17 levels and CD4+ T cell numbers. TH2-associated antibody levels (IgG1 and IgE) were significantly lower in 4- to 5-week-old Sftpd−/− mice (P < .05). Accordingly, naive Sftpd−/− splenocytes released significantly less IL-4 and IL-13 on anti-CD3/CD28 stimulation (P < .01). After intranasal allergen exposures, a modest decrease in bronchoalveolar lavage fluid eosinophilia and IL-13 levels was observed in Sftpd−/− mice compared with values seen in wild-type mice in association with decreased airway resistance (P < .01). A single nucleotide polymorphism in the SFTPD gene, affecting SP-D levels and pathogen binding, was associated with decreased atopy in black subjects and potentially lower asthma susceptibility in white subjects.

Conclusion

Sftpd−/− mice have an impaired systemic TH2 response at baseline and reduced inflammation and airway responses after allergen exposure. Translational studies revealed that a polymorphism in the SFTPD gene was associated with lower atopy and possibly asthma susceptibility. Taken together, these results support the hypothesis that SP-D–dependent innate immunity influences atopy and asthma.

Key words: Allergy, lung, surfactant protein D, polymorphism, eosinophil, IL-13, Aspergillus, endotoxin

Abbreviations used: BALF, Bronchoalveolar lavage fluid, PAS, Periodic acid-Schiff, SNP, Single nucleotide polymorphism, SP, Surfactant protein, Sftpd−/−, Surfactant protein D gene–deficient mice, TARC, Thymus and activation-regulated chemokine

 

 Supported in part by a grant from the Mechanism of Asthma and Allergic Inflammation (MAAI) 2005 Interest Section Award (E.B.B.), MECEH-Institutional NIEHS T32 ES10957-03 and CCHMC-Institutional NICHD T32 HD43005-01 grants (M.D.S.), as well as National Institutes of Health grants HL-63329 (J.A.W.), R01 AI42242, HL-076383, and AI057803 (M.E.R.).

 Disclosure of potential conflict of interest: N. Wang has received research support from the National Institutes of Health. J. A. Whitsett has a US patent (no. 6,838,429; surfactant protein D and emphysema), has received research support from the National Institutes of Health; and is on the speakers' bureau for Abbott Laboratories. M. E. Rothenberg has consulting arrangements with Ception Therapeutics, GlaxoSmith-Kline, and MedaCorp; owns stock in Ception Therapeutics; is on the speakers' bureau for Merck; and has received honoraria from GlaxoSmithKline, Ception Therapeutics, and Merck. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)00361-8

doi:10.1016/j.jaci.2008.02.011

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 5 , Pages 1140-1147.e2, May 2008